We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong value characteristics for investors to consider today, November 17th:
Innoviva, Inc. (INVA - Free Report) : This company that engages in the development and commercialization of pharmaceuticals has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 24.3% over the last 60 days.
United Natural Foods, Inc. (UNFI - Free Report) : This conventional grocery and non-food products provider has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising more than 100% over the last 60 days.
Exantas Capital Corp. : This real estate investment trust has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 17.3% over the last 60 days.
Green Plains Partners LP : This ethanol and fuel storage, terminal and transportation services provider has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 2.3% over the last 60 days.
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Image: Shutterstock
Top Ranked Value Stocks to Buy for November 17th
Here are four stocks with buy rank and strong value characteristics for investors to consider today, November 17th:
Innoviva, Inc. (INVA - Free Report) : This company that engages in the development and commercialization of pharmaceuticals has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 24.3% over the last 60 days.
Innoviva, Inc. Price and Consensus
Innoviva, Inc. price-consensus-chart | Innoviva, Inc. Quote
Innoviva has a price-to-earnings ratio (P/E) of 4.94, compared with 14.50 for the industry. The company possesses a Value Score of A.
Innoviva, Inc. PE Ratio (TTM)
Innoviva, Inc. pe-ratio-ttm | Innoviva, Inc. Quote
United Natural Foods, Inc. (UNFI - Free Report) : This conventional grocery and non-food products provider has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising more than 100% over the last 60 days.
United Natural Foods, Inc. Price and Consensus
United Natural Foods, Inc. price-consensus-chart | United Natural Foods, Inc. Quote
United Natural Foods has a price-to-earnings ratio (P/E) of 4.87, compared with 30.00 for the industry. The company possesses a Value Score of B.
United Natural Foods, Inc. PE Ratio (TTM)
United Natural Foods, Inc. pe-ratio-ttm | United Natural Foods, Inc. Quote
Exantas Capital Corp. : This real estate investment trust has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 17.3% over the last 60 days.
Exantas Capital Corp. Price and Consensus
Exantas Capital Corp. price-consensus-chart | Exantas Capital Corp. Quote
Exantas Capital has a price-to-earnings ratio (P/E) of 3.99, compared with 7.80 for the industry. The company possesses a Value Score of A.
Exantas Capital Corp. PE Ratio (TTM)
Exantas Capital Corp. pe-ratio-ttm | Exantas Capital Corp. Quote
Green Plains Partners LP : This ethanol and fuel storage, terminal and transportation services provider has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 2.3% over the last 60 days.
Green Plains Partners LP Price and Consensus
Green Plains Partners LP price-consensus-chart | Green Plains Partners LP Quote
Green Plains Partners has a price-to-earnings ratio (P/E) of 4.52, compared with 17.40 for the industry. The company possesses a Value Score of A.
Green Plains Partners LP PE Ratio (TTM)
Green Plains Partners LP pe-ratio-ttm | Green Plains Partners LP Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Download Marijuana Moneymakers FREE >>